Cardiovascular Diseases

Disease State Hub

Commentary

Heart failure

Understanding the HF Decision Pathways Report

10/01/2018

In this commentary, Dr James Januzzi explains the American College of Cardiology’s Expert Consensus Decision Pathway for managing chronic HFrEF.

10/01/2018

Nutrition

Obesity and Young Adults: Starting a Meaningful Conversation About Lifestyle Modification

09/17/2018

In this commentary, Dr Sarika Desai from Arizona Heart 360 gives advice about how to start a conversation about lifestyle modification, weight loss, and more with younger patients.

09/17/2018

Research Summaries

Research Summary

doctor at desk typing notes with clipboard in view

Research Summary

Quality of Life and Comorbidities in Adults With Congenital Heart Disease

11/15/2024

Miranda Manier, BA

A new study led by the Congenital Heart Initiative explores quality of life, mental health, and physical activity outcomes in a large cohort of adults with congenital heart disease.

11/15/2024

Research Summary

Is Increased Coronary Inflammation Driving Higher Cardiovascular Risk in People With HIV?

10/24/2024

Miranda Manier, BA

In a study that assessed pericoronary adipose tissue (PCAT) density, researchers noted an association between higher PCAT density and greater coronary plaque burden and cardiovascular disease in people with...

10/24/2024

Research Summary

Research Summary

Do Calcium Channel Blockers Lower the Risk of Bradycardia in Atrial Fibrillation?

10/12/2024

Miranda Manier, BA

A recent study found that non-dihydropyridine calcium channel blockers are associated with significantly less bradycardia during sinus rhythm compared with beta-blockers in patients with non-permanent...

10/12/2024

Research Summary

Can Statins Reduce Mortality Risk Among Older Adults With Moderate Chronic Kidney Disease?

09/24/2024

Miranda Manier, BA

Researchers developed a cohort study of more than 14,000 participants to determine whether there is an association between statin initiation and a reduced risk of mortality and major adverse cardiovascular...

09/24/2024

FDA Alert

FDA Approves Semaglutide For Reducing Serious Cardiovascular Events Among Adults With Heart Disease and Obesity, Overweight

03/21/2024

Anthony Calabro, MA

On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...

03/21/2024

November 2024

Current Issue

November 2024